MetLife Investment Management’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-43,789
| Closed | -$119K | – | 2788 |
|
|
2021
Q4 | $119K | Buy |
43,789
+23,024
| +111% | +$62.4K | ﹤0.01% | 2344 |
|
|
2021
Q3 | $92.6K | Sell |
20,765
-17,813
| -46% | -$79.4K | ﹤0.01% | 2471 |
|
|
2021
Q2 | $224K | Buy |
38,578
+25,827
| +203% | +$150K | ﹤0.01% | 2093 |
|
|
2021
Q1 | $89.5K | Sell |
12,751
-24,880
| -66% | -$175K | ﹤0.01% | 2256 |
|
|
2020
Q4 | $181K | Buy |
37,631
+3,655
| +11% | +$17.5K | ﹤0.01% | 2031 |
|
|
2020
Q3 | $198K | Hold |
33,976
| – | – | ﹤0.01% | 1870 |
|
|
2020
Q2 | $229K | Buy |
33,976
+12,009
| +55% | +$81.1K | ﹤0.01% | 1825 |
|
|
2020
Q1 | $140K | Hold |
21,967
| – | – | ﹤0.01% | 1884 |
|
|
2019
Q4 | $229K | Hold |
21,967
| – | – | ﹤0.01% | 1909 |
|
|
2019
Q3 | $86.3K | Hold |
21,967
| – | – | ﹤0.01% | 2316 |
|
|
2019
Q2 | $327K | Hold |
21,967
| – | – | ﹤0.01% | 1744 |
|
|
2019
Q1 | $545K | Hold |
21,967
| – | – | 0.01% | 1400 |
|
|
2018
Q4 | $395K | Hold |
21,967
| – | – | ﹤0.01% | 1517 |
|
|
2018
Q3 | $645K | Hold |
21,967
| – | – | 0.01% | 1369 |
|
|
2018
Q2 | $999K | Buy |
21,967
+1,764
| +9% | +$80.2K | 0.01% | 1015 |
|
|
2018
Q1 | $1.07M | Hold |
20,203
| – | – | 0.01% | 978 |
|
|
2017
Q4 | $1.37M | Buy |
+20,203
| New | +$1.37M | 0.02% | 905 |
|